MAPT and Alzheimer disease: The mechanisms underlying synaptopathy remain unclear; however, both the accumulation and aggregation of the amyloidogenic protein amyloid-β (Aβ), in particular Aβ1–42, and the hyperphosphorylation and subsequent aggregation of the cytoskeletal protein tau have been linked to the loss of synapses observed in AD [4, 5].